For: | Guo QY, Lu B, Guo ZH, Feng ZQ, Yuan YY, Jin XG, Zang P, Gu P, Shao JQ. Continuous glucose monitoring defined time-in-range is associated with sudomotor dysfunction in type 2 diabetes. World J Diabetes 2020; 11(11): 489-500 [PMID: 33269061 DOI: 10.4239/wjd.v11.i11.489] |
---|---|
URL: | https://www.wjgnet.com/1948-9358/full/v11/i11/489.htm |
Number | Citing Articles |
1 |
Trisha Shang, Jennifer Y. Zhang, Andreas Thomas, Mark A. Arnold, Beatrice N. Vetter, Lutz Heinemann, David C. Klonoff. Products for Monitoring Glucose Levels in the Human Body With Noninvasive Optical, Noninvasive Fluid Sampling, or Minimally Invasive Technologies. Journal of Diabetes Science and Technology 2022; 16(1): 168 doi: 10.1177/19322968211007212
|
2 |
Hoda Gad, Einas Elgassim, Ibrahim Mohammed, Ahmad Yaser Alhaddad, Hussein Ahmed Hussein Zaky Aly, John-John Cabibihan, Abdulaziz Al-Ali, Kishor Kumar Sadasivuni, Aliyaa Haji, Neila Lamine, Adnan Khan, Ioannis N Petropoulos, Georgios Ponirakis, Alise Kalteniece, Maryam Ferdousi, Shazli Azmi, Uazman Alam, Wajeeha Abuhelaiqa, Amin Jayyousi, Dabia AlMohanadi, Khaled Baagar, Rayaz A Malik. Continuous glucose monitoring reveals a novel association between duration and severity of hypoglycemia, and small nerve fiber injury in patients with diabetes. Endocrine Connections 2022; 11(12) doi: 10.1530/EC-22-0352
|
3 |
Ming Wang, Niuniu Chen, Yaxin Wang, Jiaying Ni, Jingyi Lu, Weijing Zhao, Yating Cui, Ronghui Du, Wei Zhu, Jian Zhou. Association of sudomotor dysfunction with risk of diabetic retinopathy in patients with type 2 diabetes. Endocrine 2024; 84(3): 951 doi: 10.1007/s12020-023-03682-3
|
4 |
Tadej Battelino, Nebojsa Lalic, Sufyan Hussain, Antonio Ceriello, Sanja Klobucar, Sarah J. Davies, Pinar Topsever, Julie Heverly, Francesca Ulivi, Kevin Brady, Tsvetalana Tankova, Júlia Galhardo, Kostas Tagkalos, Erik Werson, Chantal Mathieu, Peter Schwarz. The use of continuous glucose monitoring in people living with obesity, intermediate hyperglycemia or type 2 diabetes. Diabetes Research and Clinical Practice 2025; : 112111 doi: 10.1016/j.diabres.2025.112111
|
5 |
Rishi Raj, Rahul Mishra, Nivedita Jha, Vivek Joshi, Ricardo Correa, Philip A Kern. Time in range, as measured by continuous glucose monitor, as a predictor of microvascular complications in type 2 diabetes: a systematic review. BMJ Open Diabetes Research & Care 2022; 10(1): e002573 doi: 10.1136/bmjdrc-2021-002573
|
6 |
Evanthia Gouveri, Nikolaos Papanas. The Emerging Role of Continuous Glucose Monitoring in the Management of Diabetic Peripheral Neuropathy: A Narrative Review. Diabetes Therapy 2022; 13(5): 931 doi: 10.1007/s13300-022-01257-5
|
7 |
Ayman Al Hayek, Wael M Alzahrani, Samia H Sobki, Abdulghani H Al-Saeed, Mohamed Al Dawish. Comparison of Point-of-Care and Laboratory Glycated Hemoglobin A1c and Its Relationship to Time-in-Range and Glucose Variability: A Real-World Study. Cureus 2023; doi: 10.7759/cureus.33416
|
8 |
Ramzi A. Ajjan, Tadej Battelino, Xavier Cos, Stefano Del Prato, Jean-Christophe Philips, Laurent Meyer, Jochen Seufert, Samuel Seidu. Continuous glucose monitoring for the routine care of type 2 diabetes mellitus. Nature Reviews Endocrinology 2024; 20(7): 426 doi: 10.1038/s41574-024-00973-1
|
9 |
Ramzi A Ajjan, Tadej Battelino, J Seufert, Patrick Blin, Gérard de Pouvourville, Eric Vicaut, Laure Carcaillon-Bentata, Fleur Levrat-Guillen, Emmanuel Cosson, Michael Joubert. Do continuous glucose monitoring (CGM) metrics predict macrovascular and microvascular complications in diabetes? The FACULTY protocol of a retrospective real-world cohort study. BMJ Open 2025; 15(1): e085961 doi: 10.1136/bmjopen-2024-085961
|
10 |
Wei Cao, Jing Zou, Ming Gao, Jianv Huang, Yangyang Li, Na Li, Li Qian, Ying Zhang, Minjun Ji, Yu Liu. A comparative study of the relationship between time in range assessed by self-monitoring of blood glucose and continuous glucose monitoring with microalbuminuria outcome, HOMA-IR and HOMA-β test. Journal of Diabetes and its Complications 2024; 38(10): 108831 doi: 10.1016/j.jdiacomp.2024.108831
|
11 |
Liehua Liu, Weijian Ke, Lijuan Xu, Hai Li, Juan Liu, Xuesi Wan, Jianbin Liu, Wanping Deng, Xiaopei Cao, Haipeng Xiao, Yanbing Li. Evaluating the role of time in range as a glycemic target during short‐term intensive insulin therapy in patients with newly diagnosed type 2 diabetes. Journal of Diabetes 2023; 15(2): 133 doi: 10.1111/1753-0407.13355
|
12 |
Zhou-qin Feng, Qing-yu Guo, Wei Wang, Yan-yu Yuan, Xu-guang Jin, Hui Zhou, Jun Liu, Hai-yan Lei, Xin-yi Yang, Jun Liu, Bin Lu, Jia-qing Shao, Ping Gu. Time in range, especially overnight time in range, is associated with sudomotor dysfunction in patients with type 1 diabetes. Diabetology & Metabolic Syndrome 2021; 13(1) doi: 10.1186/s13098-021-00739-z
|
13 |
Ming Wang, Jingyi Lu, Wei Zhu, Jiaying Ni, Yaxin Wang, Jiamin Yu, Weijing Zhao, Ronghui Du, Jian Zhou. Association of Sudomotor Dysfunction With Risk of Subclinical Carotid Atherosclerosis in Patients With Type 2 Diabetes. Diabetes/Metabolism Research and Reviews 2025; 41(1) doi: 10.1002/dmrr.70030
|
14 |
Melanie A. Jackson, Andrew Ahmann, Viral N. Shah. Type 2 Diabetes and the Use of Real-Time Continuous Glucose Monitoring. Diabetes Technology & Therapeutics 2021; 23(S1): S-27 doi: 10.1089/dia.2021.0007
|
15 |
Bedia Fulya Calikoglu, Selda Celik, Cemile Idiz, Elif Bagdemir, Halim Issever, Jean-Henri Calvet, Ilhan Satman. Electrochemical skin conductances values and clinical factors affecting sudomotor dysfunction in patients with prediabetes, type 1 diabetes, and type 2 diabetes: A single center experience. Primary Care Diabetes 2023; 17(5): 499 doi: 10.1016/j.pcd.2023.06.002
|
16 |
Cesar Alejandro Figueroa-Perez, Maria Elena Romero-Ibarguengoitia, Arnulfo Garza-Silva, Iván Francisco Fernández-Chau, Andrea Belinda Cepeda-Medina, Sofía Garza-González, Dalia Gutierrez-González, Arnulfo González-Cantú. Sudoscan® reclassifies cardiovascular risk in patients with type 2 diabetes mellitus according to the ESC 2023. Journal of Diabetes & Metabolic Disorders 2025; 24(1) doi: 10.1007/s40200-024-01548-7
|